Spire Healthcare Group (LON:SPI) Reaches New 52-Week Low - Should You Sell?

Key Points

• Reached a new 52-week low: Spire's shares fell as low as GBX 148.66 (last at GBX 149) versus a prior close of GBX 189.74, on heavy volume of about 45.7 million shares.
• Weak liquidity and high leverage: The company has a current ratio of 0.63, a quick ratio of 0.74 and a very high debt-to-equity ratio of 177.14, indicating short-term liquidity pressure and significant indebtedness.
• Modest profitability and valuation: Market cap is £599.5M with a P/E of 32.39 and PEG ~1.06, while ROE is 2.22% and net margin only 1.04%; last quarter EPS was GBX 9.60 and analysts forecast ~GBX 15.66 for the year.

Spire Healthcare Group plc (LON:SPI - Get Free Report)'s stock price reached a new 52-week low during trading on Tuesday . The company traded as low as GBX 148.66 and last traded at GBX 149, with a volume of 45683051 shares. The stock had previously closed at GBX 189.74.

Spire Healthcare Group Trading Up 1.2%

The firm has a 50 day moving average of GBX 193.11 and a 200 day moving average of GBX 205.10. The firm has a market cap of £599.53 million, a PE ratio of 32.39, a P/E/G ratio of 1.06 and a beta of 0.71. The company has a quick ratio of 0.74, a current ratio of 0.63 and a debt-to-equity ratio of 177.14.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its earnings results on Friday, March 6th. The company reported GBX 9.60 earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 2.22% and a net margin of 1.04%. Equities analysts anticipate that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.